Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Salivary Gland Neoplasms × Amifostine × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 Other 1

Conditions

Xerostomia 2 Squamous Cell Carcinoma of Head and Neck 2 Radiation Injuries 2 Mucositis 2 Head and Neck Neoplasms 2 Salivary Gland Neoplasms 1 Deglutition Disorders 1

Interventions

Lysine 1 Amifostine 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated

41 enrolled 12 charts

Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡